Focus Rheums| Dr. Jekyll or Mr. Hyde? (video)

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

The Power of Advocacy

Blair Solow, MD  |  

I look forward to an ongoing conversation about how advocacy and health policy affects you and your patients and how you can help. Please join us for an advocacy event—we would love to see you! And consider investing in RheumPAC to support nonpartisan meetings with legislators about issues that impact rheumatology patients and providers.

Wishing you and yours a happy new year full of adventure—and maybe a hike.

ADVERTISEMENT
SCROLL TO CONTINUE

Blair Solow, MD, is chair of the ACR’s Government Affairs Committee and an assistant professor of medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center in Dallas.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Theodore Roosevelt and conservation. National Park Service. https://www.nps.gov/thro/learn/historyculture/theodore-roosevelt-and-conservation.htm. 2017 Nov 16.
  2. Our history. National Parks Conservation Association. https://www.npca.org/campaigns/our-history.
  3. National Park System. National Park Service. https://www.nps.gov/aboutus/national-park-system.htm. 2021 Dec 8.

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Telerheumatology: What’s Next?

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    ACR Advocacy: 2020 Year in Review

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.